Department of Pharmaceutical Sciences, St Jude Children's Research Hospital, Memphis, TN 38105, USA.
Drug Resist Updat. 2012 Feb-Apr;15(1-2):5-20. doi: 10.1016/j.drup.2012.01.009. Epub 2012 Mar 28.
Members of the solute carrier family of transporters are responsible for the cellular uptake of a broad range of endogenous compounds and xenobiotics in multiple tissues. Several of these solute carriers are known to be expressed in cancer cells or cancer cell lines, and decreased cellular uptake of drugs potentially contributes to the development of resistance. As result, the expression levels of these proteins in humans have important consequences for an individual's susceptibility to certain drug-induced side effects, interactions, and treatment efficacy. In this review article, we provide an update of this rapidly emerging field, with specific emphasis on the direct contribution of solute carriers to anticancer drug uptake in tumors, the role of these carriers in regulation of anticancer drug disposition, and recent advances in attempts to evaluate these proteins as therapeutic targets.
溶质载体家族转运体的成员负责在多种组织中摄取广泛的内源性化合物和外源性毒物。这些溶质载体中有几种已知在癌细胞或癌细胞系中表达，细胞对药物的摄取减少可能导致耐药性的发展。因此，这些蛋白质在人体内的表达水平对个体对某些药物引起的副作用、相互作用和治疗效果的易感性有重要影响。在这篇综述文章中，我们提供了这个快速发展领域的最新信息，特别强调了溶质载体对肿瘤中抗癌药物摄取的直接贡献、这些载体在抗癌药物处置中的作用，以及最近尝试将这些蛋白质作为治疗靶点的进展。
